DIETARY FAT/CHOLESTEROL AND LOW DENSITY LIPOPROTEIN

Information

  • Research Project
  • 3356186
  • ApplicationId
    3356186
  • Core Project Number
    R01HL039385
  • Full Project Number
    1R01HL039385-01A1
  • Serial Number
    39385
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1988 - 36 years ago
  • Project End Date
    6/30/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    7/1/1988 - 36 years ago
  • Budget End Date
    6/30/1989 - 35 years ago
  • Fiscal Year
    1988
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    6/30/1988 - 36 years ago
Organizations

DIETARY FAT/CHOLESTEROL AND LOW DENSITY LIPOPROTEIN

The overall objective of this research is to investigate the effects of nutrition intervention on low density lipoprotein (LDL) metabolism using a nonhuman primate model (Macaca fascicularis). The dietary treatment will include three levels of fat (40, 30 and 20% of calories), with fat types composed of P/S ratios of 0.45, 1.0 and 2.0 and cholesterol intakes of 100 and 240 mg/1000 kcals to be fed sequentially at six-month intervals. Recent observations in this monkey model indicate that animals maintained on the 30% calories as fat, P/S ratio of 1.0 and the equivalent of 120mg cholesterol/1000 kcals have lower LDL cholesterol (-32%), higher high density lipoprotein (HDL) cholesterol (+16%) and higher apo A-I levels (+33%) than monkeys maintained on the higher fat levels (42% kcals as fat). On the otherhand, monkeys on the lower fat level and higher P/S ratio (1.0) have higher apo B levels than monkeys fed the diet with an equivalent P/S ratio but the higher fat level (42% kcals). This not only emphasizes the importance of investigating dietary fat level/fat type interactions but also suggests that diet effects on LDL cholesterol and apo B may be dissimilar. Thus, in this sensitive animal model, we are proposing to utilize biochemical and molecular biology approaches to investigate diet determinants of LDL metabolism by (a) measuring plasma lipids and apoproteins (b) assessing receptor-dependent and receptor-independent pathways of LDL metabolism in vivo. (c) measuring levels of hepatic mRNA for apo B to document the relationship of apo B mRNA to parameters of LDL metabolism defined in vivo and in the in vitro isolated liver perfusion system (d) measuring levels of hepatic LDL receptor mRNA and correlating them with receptor dependent LDL catabolic rates and (e) characterizing the LDL and/or LDL-"like" particles formed as well as the apo B synthetic rates using an in vitro liver perfusion system.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
    SCH ALLIED HEALTH PROFESSIONS
  • Funding ICs
  • Funding Mechanism
  • Study Section
    NTN
  • Study Section Name
    Nutrition Study Section
  • Organization Name
    UNIVERSITY OF LOWELL
  • Organization Department
  • Organization DUNS
  • Organization City
    LOWELL
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01854
  • Organization District
    UNITED STATES